Talimogene laherparepvec in combination with pembrolizumab leads to a complete response in a patient with refractory Merkel cell carcinoma

Detalles Bibliográficos
Autores principales: Lara, Kristi M., In, Gino K., Matcuk, George R., Mehta, Arjun, Hu, James S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226586/
https://www.ncbi.nlm.nih.gov/pubmed/30450405
http://dx.doi.org/10.1016/j.jdcr.2018.10.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226586/
https://www.ncbi.nlm.nih.gov/pubmed/30450405
http://dx.doi.org/10.1016/j.jdcr.2018.10.003

Ejemplares similares